Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001181431-10-036838

SVP & GENERAL COUNSEL acquired 4,101 shares (option exercise)

  • SVP & GENERAL COUNSEL disposed of 2,051 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Ozeroff Christopher David · SVP & GENERAL COUNSEL

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2010-07-02 Exercise or conversion : show line 1 in the form +4,101 $0.06 $246 43,809 D
2010-07-07 Other disposition : show line 2 in the form −2,051 41,758 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-07-02 Exercise or conversion : show line 3 in the form Option to purchase Common Stock +4,101 $0.06 2015-01-03 4,101 0 D
Loading xslF345X03/rrd281035.xml…